ALKS | Alkermes Inc.NASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$45.69
+$0.80 (+1.78%)

Alkermes Inc. (ALKS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Jan 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $45.69 vs 50 $43.92 / 200 $40.61
Projection
No cross projected
Test
No active test
Last cross
Golden cross 7 Jan 2026 ยท projected 1 bar out ยท tested 5 bars

Weekly as of 30 Oct 16:00 ET

Price
above both $45.34 vs 50 $38.52 / 200 $30.96
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 21 Mar 2022 ยท projected 11 bars out ยท tested 2 bars

Cross history

32
crosses on record since 2017
16 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
25 Sep 2026Death4-hour27 bars outNot tested
14 Apr 2026Golden4-hour15 bars outNot tested
18 Mar 2026Death4-hour27 bars outNot tested
26 Jan 2026Golden4-hour19 bars outNot tested
7 Jan 2026Golden flatdaily1 bar out5 bar cross test

About ALKS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$71.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.